These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21325726)

  • 1. Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.
    Wang N; Yin R; Liu Y; Mao G; Xi F
    Circ J; 2011; 75(3):528-35. PubMed ID: 21325726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma and cardiovascular diseases.
    Takano H; Komuro I
    Circ J; 2009 Feb; 73(2):214-20. PubMed ID: 19129679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis.
    Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN
    Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology.
    Ciudin A; Hernandez C; Simó R
    Curr Top Med Chem; 2012; 12(6):585-604. PubMed ID: 22242856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma in vascular biology.
    Li J; Wang N
    Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):109-17. PubMed ID: 17584045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery.
    Ivanova EA; Parolari A; Myasoedova V; Melnichenko AA; Bobryshev YV; Orekhov AN
    J Cardiol; 2015 Oct; 66(4):271-8. PubMed ID: 26072262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
    Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many faces of PPARgamma.
    Lehrke M; Lazar MA
    Cell; 2005 Dec; 123(6):993-9. PubMed ID: 16360030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma.
    Gerry JM; Pascual G
    Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Libby P; Plutzky J
    Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PPAR receptors and insulin sensitivity: new agonists in development].
    Pégorier JP
    Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S10-7. PubMed ID: 15959400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
    Sharma AM; Staels B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.
    Blaschke F; Caglayan E; Hsueh WA
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):561-74, ix. PubMed ID: 16959586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.
    Ray DM; Spinelli SL; O'Brien JJ; Blumberg N; Phipps RP
    BioDrugs; 2006; 20(4):231-41. PubMed ID: 16831022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease.
    Hsueh WA; Bruemmer D
    Hypertension; 2004 Feb; 43(2):297-305. PubMed ID: 14732733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PPAR-gamma receptors, new therapeutic target in metabolic and cardiovascular diseases].
    Scheen AJ; Paquot N
    Rev Med Liege; 2005 Feb; 60(2):89-95. PubMed ID: 15819371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.